Oxaliplatin Injection, Solution
Product Images NDC 72603-420

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 72603-420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 100 mg Carton (Oxali 100mg Ns Carton)

Carton label for Oxaliplatin Injection, USP 100 mg per 20 mL (5 mg per mL) solution for intravenous use. The label prominently displays the brand and generic name, strength, dosage form, and a warning that the solution must not be diluted with sodium chloride or chloride-containing solutions. It is a sterile aqueous solution requiring dilution with 5% dextrose injection. The label includes storage instructions, manufacturer details (Northstar Rx LLC), and a barcode.*

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 100 mg Vial Label (Oxali 100mg Ns Vial)

Oxaliplatin Injection, USP 100 mg per 20 mL (5 mg per mL) single-dose vial for intravenous use by Northstar Rx LLC. Label includes a caution indicating it as a cytotoxic agent with a warning not to dilute in sodium chloride/chloride-containing solutions. The vial is preservative-free, with 5.0% dextrose as the diluent.*

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 50 mg Carton (Oxali 50mg Ns Carton)

Carton packaging label for Oxaliplatin Injection, USP 50 mg per 10 mL (5 mg per mL) solution for intravenous use. Label indicates it is a sterile aqueous, preservative-free cytotoxic agent that must be diluted prior to use with 5% dextrose injection. The carton is labeled for Northstar Rx LLC, with additional storage and usage instructions, caution statements, and a barcode.*

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 50 mg Vial Label (Oxali 50mg Ns Vial)

Label for Oxaliplatin Injection, USP, 50 mg per 10 mL (5 mg per mL) intravenous solution. The sterile aqueous solution is preservative free and must be diluted prior to use with 5% dextrose injection. The label includes warnings not to dilute in sodium chloride/chloride-containing solutions and specifies a 10 mL single-dose vial. Manufactured by Northstar Rx LLC.*

FDA Label Image

Figure 1 (Oxali Ns Fig 1)

A Kaplan-Meier survival curve comparing disease-free survival probability over months between two treatment arms labeled FOLFOX4 and LV5FU2. The graph shows the number of patients at risk at various time points up to 72 months, hazard ratio with confidence interval, and a p-value from a stratified logrank test, indicating statistical comparison of the two groups.*

FDA Label Image

Figure 2 (Oxali Ns Fig 2)

A Kaplan-Meier survival curve chart showing disease-free survival (DFS) probability over time in months for Stage III patients. The chart compares two treatment arms: FOLFOX4 versus LV5FU2, both combined with DUKES C, with DFS probability on the y-axis and time in months on the x-axis. Statistical values including a hazard ratio with 95% confidence interval and a p-value from the logrank test are displayed.*

FDA Label Image

Figure 3 (Oxali Ns Fig 3)

A survival curve chart comparing the percentage of patients surviving over 24 months among three treatment groups: Oxaliplatin + 5-FU/LV, Oxaliplatin + irinotecan, and Irinotecan + 5-FU/LV. The chart shows median survival times in months for each group, with Oxaliplatin + 5-FU/LV having the highest median survival of 19.4 months. The chart includes a p-value indicating statistical significance.*

FDA Label Image

Structure (Oxali Ns Structure)

Chemical structure of oxaliplatin showing a platinum atom coordinated with amine and oxalate ligands. The image illustrates the molecular arrangement typical of oxaliplatin, an intravenous injection solution drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.